查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1405860

肝素市场规模、份额、趋势分析报告：按类型、给药途径、最终用途、原产地、地区、细分市场预测，2024-2030

Heparin Market Size, Share & Trends Analysis Report By Type, By Route of Administration, By Application, By End-use (Outpatient, Inpatient), By Source, By Region, And Segment Forecasts, 2024 - 2030
出版日期: | 出版商: Grand View Research | 英文 111 Pages | 商品交期: 2-10个工作天内

价格

肝素市场成长与趋势：

Grand View Research, Inc.最新报告显示，预计到2030年，全球肝素市场规模将达到90.3亿美元，2024年至2030年复合年增长率为2.7%。

老年人口的增加和输血需求的增加是推动市场成长的主要因素。此外，COVID-19的爆发进一步推动了市场的成长。例如，根据 2022 年《柳叶刀》杂誌报道，由于在 COVID-19 患者中使用肝素来预防血栓，因此对肝素的需求恶化。

感染疾病治疗中对血液成分、输血和血浆衍生物的需求不断增加预计将推动市场的发展。例如，根据美国红十字会2022年的数据，美国每年约输注1,600万份血液成分。此外，由于 COVID-19 大流行而推迟的手术数量激增，进一步增加了对预防血栓的肝素的需求。

据估计，老年人口的增加将推动市场成长。根据联合国估计，到2020年，全球60岁或以上的人口将约为7.27亿人。此外，65岁及以上老年人口比例预计将从2020年的9.3%增加到2050年的16%。老年族群接受复杂手术的比例更高，因此血栓和深层静脉栓塞症等相关疾病的发生率明显更高，预计将推动对肝素作为抗凝血剂的需求。

外科手术数量的增加是加速全血和输血需求的关键因素。例如，2020年全球每年进行的大手术数量已达到3.1亿例，其中美国进行了4000至5000万例，欧洲进行了约2000万例。预计这些手术将增加对肝素的需求。

随着口服抗凝血剂动态的变化，我们预期市场竞争者之间的敌意将减少。参与者参与发现肝素等抗凝血剂的新给药途径预计将改变预测期内的市场状况。提供学名药的企业数量不断增加，也加剧了竞争公司之间的敌对关係。

肝素市场报告亮点

  • 由于处方率和需求较高，低分子肝素 (LMWH) 细分市场在 2023 年占据最大的销售份额。
  • 由于其成本效益和给药程序的简单性，皮下给药途径在 2023 年占据了最大的销售份额。
  • 由于冠状动脉疾病盛行率上升以及住院患者肝素注射的使用增加，冠状动脉疾病细分市场将在 2022 年占据主导地位。
  • 由于医院加大门诊病人服务力道以及越来越多的患者选择门诊治疗，预计到2023年，门诊病人业务将占据最大的收益占有率。
  • 猪源性肝素预计将主导市场，因为它用于生产低分子量肝素。
  • 由于医疗保健完善且人口众多，预计亚太地区在预测期内将出现最快的成长。

目录

第一章调查方法与范围

第 2 章执行摘要

第三章肝素市场变数、趋势和范围

  • 市场体系展望
    • 母市场展望
    • 相关/附随市场展望
  • 市场动态
    • 市场驱动因素分析
    • 市场抑制因素分析
  • 肝素市场分析工具
    • 产业分析-波特五力分析
    • PESTEL分析

第四章 肝素市场：类型估计与趋势分析

  • 类型市场占有率，2023/2030
  • 细分仪表板
  • 按类型分類的全球肝素市场展望
  • 2018-2030 年市场规模、预测与趋势分析如下
    • 低分子肝素
    • 超低分子肝素
    • 未分级肝素

第五章 肝素市场：给药途径预估及趋势分析

  • 2023 年及 2030 年给药途径市场占有率
  • 细分仪表板
  • 按给药途径分類的全球肝素市场展望
  • 2018-2030 年市场规模、预测与趋势分析如下
    • 静脉
    • 皮下的

第六章肝素市场：应用估算与趋势分析

  • 2023年及2030年应用市场占有率
  • 细分仪表板
  • 全球肝素市场应用展望
  • 2018-2030 年市场规模、预测与趋势分析如下
    • 静脉血栓栓塞症
    • 心房颤动
    • 肾衰竭
    • 冠状动脉疾病
    • 其他的

第七章肝素市场：最终用途估计和趋势分析

  • 2023 年及 2030 年最终用途市场占有率
  • 细分仪表板
  • 以最终用途分類的全球肝素市场展望
  • 2018-2030 年市场规模、预测与趋势分析如下
    • 门诊
    • 住院病人

第八章 肝素市场：起源估计与趋势分析

  • 原产地市场占有率，2023/2030
  • 细分仪表板
  • 按产地分類的全球肝素市场前景
  • 2018-2030 年市场规模、预测与趋势分析如下
    • 猪
    • 牛
    • 其他的

第九章肝素市场：按地区估算及趋势分析

  • 2023/2030 年区域市场占有率分析
  • 区域市场仪表板
  • 全球区域市场概况
  • 2018-2030年市场规模及预测趋势分析
  • 北美洲
    • 美国
    • 加拿大
  • 欧洲
    • 英国
    • 德国
    • 法国
    • 义大利
    • 西班牙
    • 挪威
    • 瑞典
    • 丹麦
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 韩国
    • 泰国
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
  • 中东/非洲
    • 南非
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 科威特

第10章竞争形势

  • 主要市场参与企业的最新趋势和影响分析
  • 公司/竞争分类
  • 供应商形势
    • List of key distributors and channel partners
    • Key customers
    • Key company market share analysis, 2023
    • Pfizer Inc.
    • LEO Pharma A/S
    • Dr. Reddy's Laboratories Ltd.
    • GlaxoSmithKline plc
    • Sanofi
    • Aspen Holdings
    • Fresenius SE &Co. KGaA
    • B. Braun Medical, Inc.
    • Sandoz（Novartis AG）
Product Code: GVR-3-68038-154-2

Heparin Market Growth & Trends:

The global heparin market size is expected to reach USD 9.03 billion by 2030, expanding at a CAGR of 2.7% from 2024 to 2030, according to a new report by Grand View Research, Inc. The increasing geriatric population and heightened demand for transfusions are key factors propelling the market growth. Moreover, the outbreak of COVID-19 has further propelled the market growth. For instance, as per The Lancet Journal in 2022, the demand for heparin exacerbated attributable to its use in COVID-19 patients for thromboprophylaxis.

Increasing demand for blood components, transfusion, and plasma derivatives in the treatment of infectious diseases is expected to drive the market. For instance, according to American Red Cross in 2022, around 16 million blood components are transfused each year in the U.S. Furthermore, the surge in the number of surgeries that were delayed due to the COVID-19 pandemic has further escalated the demand for heparin for blood-clot prevention.

The growing geriatric population is estimated to fuel the market growth. According to United Nations, it was estimated that, in 2020, there were around 727 million people with ages above 60 years worldwide. In addition, the percentage share of the aged population above 65 years is estimated to increase from 9.3% in 2020 to 16% in 2050. The geriatric population has a higher rate of complex surgeries and thus is anticipated to propel the demand for heparin as an anticoagulant, as this population has a significantly higher rate of developing blood clots and related conditions such as deep vein thrombosis.

The growing number of surgeries is a key factor accelerating the demand for whole blood and transfusions. For instance, the annual number of major surgeries performed globally has reached 310 million, 40 to 50 million surgeries performed in the U.S., and around 20 million were performed in Europe in 2020. These surgeries are projected to escalate the demand for heparin.

The competitive rivalry in the marketplace is expected to be moderate due to changing dynamics towards oral anticoagulants. The involvement of players in discovering novel routes of administration for anticoagulants such as heparin is expected to change the market scenario over the forecast period. The rising number of players offering generics also increases competitive rivalry.

Heparin Market Report Highlights:

  • The Low Molecular Weight Heparin (LMWH) segment held the largest revenue share in 2023 owing to its high prescription rate and demand
  • The subcutaneous route of administration segment held the largest revenue share in 2023 owing to its cost-effective nature and easier procedure for administration
  • The coronary artery disease segment dominated the market in 2022 owing to the rising incidence of coronary artery disease and increased use of heparin injection in hospitalized patients
  • The outpatient segment is expected to hold the largest revenue share in 2023 owing to the initiatives undertaken by hospitals for outpatient services and the increased preference of patients for outpatient treatment
  • Porcine-derived heparin is expected to dominate the market due to its use in the production of low molecular weight heparin
  • Asia Pacific is expected to exhibit the fastest growth over the forecast period due to the growing establishment of healthcare, and a large population base

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Type
    • 1.2.2. Route of administration
    • 1.2.3. Application
    • 1.2.4. End-use
    • 1.2.5. Source
    • 1.2.6. Regional scope
    • 1.2.7. Estimates and forecasts timeline
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased database
    • 1.4.2. GVR's internal database
    • 1.4.3. Secondary sources
    • 1.4.4. Primary research
    • 1.4.5. Details of primary research
      • 1.4.5.1. Data for primary interviews in North America
      • 1.4.5.2. Data for primary interviews in Europe
      • 1.4.5.3. Data for primary interviews in Asia Pacific
      • 1.4.5.4. Data for primary interviews in Latin America
      • 1.4.5.5. Data for Primary interviews in MEA
  • 1.5. Information or Data Analysis
    • 1.5.1. Data analysis models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity flow analysis (Model 1)
    • 1.7.2. Approach 1: Commodity flow approach
    • 1.7.3. Volume price analysis (Model 2)
    • 1.7.4. Approach 2: Volume price analysis
  • 1.8. List of Secondary Sources
  • 1.9. List of Primary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Type
    • 2.2.2. Route of Administration
    • 2.2.3. Application
    • 2.2.4. End-use
    • 2.2.5. Source
    • 2.2.6. Regional outlook
  • 2.3. Competitive Insights

Chapter 3. Heparin Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
      • 3.2.1.1. Increasing prevalence of chronic diseases
      • 3.2.1.2. Growing demand for whole blood and blood components transfusion
      • 3.2.1.3. Increasing geriatric population
      • 3.2.1.4. High usage of plasma in the pharmaceutical industry
    • 3.2.2. Market restraint analysis
      • 3.2.2.1. Risk of blood-transmitted diseases and an increasing number of blood substitutes
      • 3.2.2.2. Emerging oral anticoagulants
  • 3.3. Heparin Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
      • 3.3.1.1. Supplier power
      • 3.3.1.2. Buyer power
      • 3.3.1.3. Substitution threat
      • 3.3.1.4. Threat of new entrant
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political landscape
      • 3.3.2.2. Technological landscape
      • 3.3.2.3. Economic landscape

Chapter 4. Heparin Market: Type Estimates & Trend Analysis

  • 4.1. Type Market Share, 2023 & 2030
  • 4.2. Segment Dashboard
  • 4.3. Global Heparin Market by Type Outlook
  • 4.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
    • 4.4.1. Low Molecular Weight Heparin
      • 4.4.1.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
    • 4.4.2. Ultra-low Molecular Weight Heparin
      • 4.4.2.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
    • 4.4.3. Unfractionated Heparin
      • 4.4.3.1. Market estimates and forecasts, 2018 - 2030 (USD Million)

Chapter 5. Heparin Market: Route of Administration Estimates & Trend Analysis

  • 5.1. Route of Administration Market Share, 2023 & 2030
  • 5.2. Segment Dashboard
  • 5.3. Global Heparin Market by Route of Administration Outlook
  • 5.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
    • 5.4.1. Intravenous
      • 5.4.1.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
    • 5.4.2. Subcutaneous
      • 5.4.2.1. Market estimates and forecasts, 2018 - 2030 (USD Million)

Chapter 6. Heparin Market: Application Estimates & Trend Analysis

  • 6.1. Application Market Share, 2023 & 2030
  • 6.2. Segment Dashboard
  • 6.3. Global Heparin Market by Application Outlook
  • 6.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
    • 6.4.1. Venous Thromboembolism
      • 6.4.1.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
    • 6.4.2. Atrial Fibrillation
      • 6.4.2.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
    • 6.4.3. Renal Impairment
      • 6.4.3.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
    • 6.4.4. Coronary Artery Disease
      • 6.4.4.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
    • 6.4.5. Others
      • 6.4.5.1. Market estimates and forecasts, 2018 - 2030 (USD Million)

Chapter 7. Heparin Market: End-use Estimates & Trend Analysis

  • 7.1. End-use Market Share, 2023 & 2030
  • 7.2. Segment Dashboard
  • 7.3. Global Heparin Market by End-use Outlook
  • 7.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
    • 7.4.1. Outpatient
      • 7.4.1.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
    • 7.4.2. Inpatient
      • 7.4.2.1. Market estimates and forecasts, 2018 - 2030 (USD Million)

Chapter 8. Heparin Market: Source Estimates & Trend Analysis

  • 8.1. Source Market Share, 2023 & 2030
  • 8.2. Segment Dashboard
  • 8.3. Global Heparin Market by Source Outlook
  • 8.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
    • 8.4.1. Porcine
      • 8.4.1.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
    • 8.4.2. Bovine
      • 8.4.2.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
    • 8.4.3. Others
      • 8.4.3.1. Market estimates and forecasts, 2018 - 2030 (USD Million)

Chapter 9. Heparin Market: Regional Estimates & Trend Analysis

  • 9.1. Regional Market Share Analysis, 2023 & 2030
  • 9.2. Regional Market Dashboard
  • 9.3. Global Regional Market Snapshot
  • 9.4. Market Size, & Forecasts Trend Analysis, 2018 to 2030
  • 9.5. North America
    • 9.5.1. U.S.
      • 9.5.1.1. Key country dynamics
      • 9.5.1.2. Regulatory framework/ reimbursement structure
      • 9.5.1.3. Competitive scenario
      • 9.5.1.4. U.S. market estimates and forecasts, 2018 - 2030 (USD Million)
    • 9.5.2. Canada
      • 9.5.2.1. Key country dynamics
      • 9.5.2.2. Regulatory framework/ reimbursement structure
      • 9.5.2.3. Competitive scenario
      • 9.5.2.4. Canada market estimates and forecasts, 2018 - 2030 (USD Million)
  • 9.6. Europe
    • 9.6.1. UK
      • 9.6.1.1. Key country dynamics
      • 9.6.1.2. Regulatory framework/ reimbursement structure
      • 9.6.1.3. Competitive scenario
      • 9.6.1.4. UK market estimates and forecasts, 2018 - 2030 (USD Million)
    • 9.6.2. Germany
      • 9.6.2.1. Key country dynamics
      • 9.6.2.2. Regulatory framework/ reimbursement structure
      • 9.6.2.3. Competitive scenario
      • 9.6.2.4. Germany market estimates and forecasts, 2018 - 2030 (USD Million)
    • 9.6.3. France
      • 9.6.3.1. Key country dynamics
      • 9.6.3.2. Regulatory framework/ reimbursement structure
      • 9.6.3.3. Competitive scenario
      • 9.6.3.4. France market estimates and forecasts, 2018 - 2030 (USD Million)
    • 9.6.4. Italy
      • 9.6.4.1. Key country dynamics
      • 9.6.4.2. Regulatory framework/ reimbursement structure
      • 9.6.4.3. Competitive scenario
      • 9.6.4.4. Italy market estimates and forecasts, 2018 - 2030 (USD Million)
    • 9.6.5. Spain
      • 9.6.5.1. Key country dynamics
      • 9.6.5.2. Regulatory framework/ reimbursement structure
      • 9.6.5.3. Competitive scenario
      • 9.6.5.4. Spain market estimates and forecasts, 2018 - 2030 (USD Million)
    • 9.6.6. Norway
      • 9.6.6.1. Key country dynamics
      • 9.6.6.2. Regulatory framework/ reimbursement structure
      • 9.6.6.3. Competitive scenario
      • 9.6.6.4. Norway market estimates and forecasts, 2018 - 2030 (USD Million)
    • 9.6.7. Sweden
      • 9.6.7.1. Key country dynamics
      • 9.6.7.2. Regulatory framework/ reimbursement structure
      • 9.6.7.3. Competitive scenario
      • 9.6.7.4. Sweden market estimates and forecasts, 2018 - 2030 (USD Million)
    • 9.6.8. Denmark
      • 9.6.8.1. Key country dynamics
      • 9.6.8.2. Regulatory framework/ reimbursement structure
      • 9.6.8.3. Competitive scenario
      • 9.6.8.4. Denmark market estimates and forecasts, 2018 - 2030 (USD Million)
  • 9.7. Asia Pacific
    • 9.7.1. Japan
      • 9.7.1.1. Key country dynamics
      • 9.7.1.2. Regulatory framework/ reimbursement structure
      • 9.7.1.3. Competitive scenario
      • 9.7.1.4. Japan market estimates and forecasts, 2018 - 2030 (USD Million)
    • 9.7.2. China
      • 9.7.2.1. Key country dynamics
      • 9.7.2.2. Regulatory framework/ reimbursement structure
      • 9.7.2.3. Competitive scenario
      • 9.7.2.4. China market estimates and forecasts, 2018 - 2030 (USD Million)
    • 9.7.3. India
      • 9.7.3.1. Key country dynamics
      • 9.7.3.2. Regulatory framework/ reimbursement structure
      • 9.7.3.3. Competitive scenario
      • 9.7.3.4. India market estimates and forecasts, 2018 - 2030 (USD Million)
    • 9.7.4. Australia
      • 9.7.4.1. Key country dynamics
      • 9.7.4.2. Regulatory framework/ reimbursement structure
      • 9.7.4.3. Competitive scenario
      • 9.7.4.4. Australia market estimates and forecasts, 2018 - 2030 (USD Million)
    • 9.7.5. South Korea
      • 9.7.5.1. Key country dynamics
      • 9.7.5.2. Regulatory framework/ reimbursement structure
      • 9.7.5.3. Competitive scenario
      • 9.7.5.4. South Korea market estimates and forecasts, 2018 - 2030 (USD Million)
    • 9.7.6. Thailand
      • 9.7.6.1. Key country dynamics
      • 9.7.6.2. Regulatory framework/ reimbursement structure
      • 9.7.6.3. Competitive scenario
      • 9.7.6.4. Thailand market estimates and forecasts, 2018 - 2030 (USD Million)
  • 9.8. Latin America
    • 9.8.1. Brazil
      • 9.8.1.1. Key country dynamics
      • 9.8.1.2. Regulatory framework/ reimbursement structure
      • 9.8.1.3. Competitive scenario
      • 9.8.1.4. Brazil market estimates and forecasts, 2018 - 2030 (USD Million)
    • 9.8.2. Mexico
      • 9.8.2.1. Key country dynamics
      • 9.8.2.2. Regulatory framework/ reimbursement structure
      • 9.8.2.3. Competitive scenario
      • 9.8.2.4. Mexico market estimates and forecasts, 2018 - 2030 (USD Million)
    • 9.8.3. Argentina
      • 9.8.3.1. Key country dynamics
      • 9.8.3.2. Regulatory framework/ reimbursement structure
      • 9.8.3.3. Competitive scenario
      • 9.8.3.4. Argentina market estimates and forecasts, 2018 - 2030 (USD Million)
  • 9.9. MEA
    • 9.9.1. South Africa
      • 9.9.1.1. Key country dynamics
      • 9.9.1.2. Regulatory framework/ reimbursement structure
      • 9.9.1.3. Competitive scenario
      • 9.9.1.4. South Africa market estimates and forecasts, 2018 - 2030 (USD Million)
    • 9.9.2. Saudi Arabia
      • 9.9.2.1. Key country dynamics
      • 9.9.2.2. Regulatory framework/ reimbursement structure
      • 9.9.2.3. Competitive scenario
      • 9.9.2.4. Saudi Arabia market estimates and forecasts, 2018 - 2030 (USD Million)
    • 9.9.3. UAE
      • 9.9.3.1. Key country dynamics
      • 9.9.3.2. Regulatory framework/ reimbursement structure
      • 9.9.3.3. Competitive scenario
      • 9.9.3.4. UAE market estimates and forecasts, 2018 - 2030 (USD Million)
    • 9.9.4. Kuwait
      • 9.9.4.1. Key country dynamics
      • 9.9.4.2. Regulatory framework/ reimbursement structure
      • 9.9.4.3. Competitive scenario
      • 9.9.4.4. Kuwait market estimates and forecasts, 2018 - 2030 (USD Million)

Chapter 10. Competitive Landscape

  • 10.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 10.2. Company/Competition Categorization
  • 10.3. Vendor Landscape
    • 10.3.1. List of key distributors and channel partners
    • 10.3.2. Key customers
    • 10.3.3. Key company market share analysis, 2023
    • 10.3.4. Pfizer Inc.
      • 10.3.4.1. Company overview
      • 10.3.4.2. Financial performance
      • 10.3.4.3. Type benchmarking
      • 10.3.4.4. Strategic initiatives
    • 10.3.5. LEO Pharma A/S
      • 10.3.5.1. Company overview
      • 10.3.5.2. Financial performance
      • 10.3.5.3. Type benchmarking
      • 10.3.5.4. Strategic initiatives
    • 10.3.6. Dr. Reddy's Laboratories Ltd.
      • 10.3.6.1. Company overview
      • 10.3.6.2. Financial performance
      • 10.3.6.3. Type benchmarking
      • 10.3.6.4. Strategic initiatives
    • 10.3.7. GlaxoSmithKline plc
      • 10.3.7.1. Company overview
      • 10.3.7.2. Financial performance
      • 10.3.7.3. Type benchmarking
      • 10.3.7.4. Strategic initiatives
    • 10.3.8. Sanofi
      • 10.3.8.1. Company overview
      • 10.3.8.2. Financial performance
      • 10.3.8.3. Type benchmarking
      • 10.3.8.4. Strategic initiatives
    • 10.3.9. Aspen Holdings
      • 10.3.9.1. Company overview
      • 10.3.9.2. Financial performance
      • 10.3.9.3. Type benchmarking
      • 10.3.9.4. Strategic initiatives
    • 10.3.10. Fresenius SE & Co. KGaA
      • 10.3.10.1. Company overview
      • 10.3.10.2. Financial performance
      • 10.3.10.3. Type benchmarking
      • 10.3.10.4. Strategic initiatives
    • 10.3.11. B. Braun Medical, Inc.
      • 10.3.11.1. Company overview
      • 10.3.11.2. Financial performance
      • 10.3.11.3. Type benchmarking
      • 10.3.11.4. Strategic initiatives
    • 10.3.12. Sandoz (Novartis AG)
      • 10.3.12.1. Company overview
      • 10.3.12.2. Financial performance
      • 10.3.12.3. Type benchmarking
      • 10.3.12.4. Strategic initiatives

List of Tables

  • Table 1 List of abbreviations
  • Table 2 North America Heparin market, by region, 2018 - 2030 (USD Million)
  • Table 3 North America Heparin market, by type, 2018 - 2030 (USD Million)
  • Table 4 North America Heparin market, by route of administration, 2018 - 2030 (USD Million)
  • Table 5 North America Heparin market, by application, 2018 - 2030 (USD Million)
  • Table 6 North America Heparin market, by end-use, 2018 - 2030 (USD Million)
  • Table 7 North America Heparin market, by source, 2018 - 2030 (USD Million)
  • Table 8 U.S. Heparin market, by type, 2018 - 2030 (USD Million)
  • Table 9 U.S. Heparin market, by route of administration, 2018 - 2030 (USD Million)
  • Table 10 U.S. Heparin market, by application, 2018 - 2030 (USD Million)
  • Table 11 U.S. Heparin market, by end-use, 2018 - 2030 (USD Million)
  • Table 12 U.S. Heparin market, by source, 2018 - 2030 (USD Million)
  • Table 13 Canada Heparin market, by type, 2018 - 2030 (USD Million)
  • Table 14 Canada Heparin market, by route of administration, 2018 - 2030 (USD Million)
  • Table 15 Canada Heparin market, by application, 2018 - 2030 (USD Million)
  • Table 16 Canada Heparin market, by end-use, 2018 - 2030 (USD Million)
  • Table 17 Canada Heparin market, by source, 2018 - 2030 (USD Million)
  • Table 18 Europe Heparin market, by region, 2018 - 2030 (USD Million)
  • Table 19 Europe Heparin market, by type, 2018 - 2030 (USD Million)
  • Table 20 Europe Heparin market, by route of administration, 2018 - 2030 (USD Million)
  • Table 21 Europe Heparin market, by application, 2018 - 2030 (USD Million)
  • Table 22 Europe Heparin market, by end-use, 2018 - 2030 (USD Million)
  • Table 23 Europe Heparin market, by source, 2018 - 2030 (USD Million)
  • Table 24 Germany Heparin market, by type, 2018 - 2030 (USD Million)
  • Table 25 Germany Heparin market, by route of administration, 2018 - 2030 (USD Million)
  • Table 26 Germany Heparin market, by application, 2018 - 2030 (USD Million)
  • Table 27 Germany Heparin market, by end-use, 2018 - 2030 (USD Million)
  • Table 28 Germany Heparin market, by source, 2018 - 2030 (USD Million)
  • Table 29 UK Heparin market, by type, 2018 - 2030 (USD Million)
  • Table 30 UK Heparin market, by route of administration, 2018 - 2030 (USD Million)
  • Table 31 UK Heparin market, by application, 2018 - 2030 (USD Million)
  • Table 32 UK Heparin market, by end-use, 2018 - 2030 (USD Million)
  • Table 33 UK Heparin market, by source, 2018 - 2030 (USD Million)
  • Table 34 France Heparin market, by type, 2018 - 2030 (USD Million)
  • Table 35 France Heparin market, by route of administration, 2018 - 2030 (USD Million)
  • Table 36 France Heparin market, by application, 2018 - 2030 (USD Million)
  • Table 37 France Heparin market, by end-use, 2018 - 2030 (USD Million)
  • Table 38 France Heparin market, by source, 2018 - 2030 (USD Million)
  • Table 39 Italy Heparin market, by type, 2018 - 2030 (USD Million)
  • Table 40 Italy Heparin market, by route of administration, 2018 - 2030 (USD Million)
  • Table 41 Italy Heparin market, by application, 2018 - 2030 (USD Million)
  • Table 42 Italy Heparin market, by end-use, 2018 - 2030 (USD Million)
  • Table 43 Italy Heparin market, by source, 2018 - 2030 (USD Million)
  • Table 44 Spain Heparin market, by type, 2018 - 2030 (USD Million)
  • Table 45 Spain Heparin market, by route of administration, 2018 - 2030 (USD Million)
  • Table 46 Spain Heparin market, by application, 2018 - 2030 (USD Million)
  • Table 47 Spain Heparin market, by end-use, 2018 - 2030 (USD Million)
  • Table 48 Spain Heparin market, by source, 2018 - 2030 (USD Million)
  • Table 49 Denmark Heparin market, by type, 2018 - 2030 (USD Million)
  • Table 50 Denmark Heparin market, by route of administration, 2018 - 2030 (USD Million)
  • Table 51 Denmark Heparin market, by application, 2018 - 2030 (USD Million)
  • Table 52 Denmark Heparin market, by end-use, 2018 - 2030 (USD Million)
  • Table 53 Denmark Heparin market, by source, 2018 - 2030 (USD Million)
  • Table 54 Sweden Heparin market, by type, 2018 - 2030 (USD Million)
  • Table 55 Sweden Heparin market, by route of administration, 2018 - 2030 (USD Million)
  • Table 56 Sweden Heparin market, by application, 2018 - 2030 (USD Million)
  • Table 57 Sweden Heparin market, by end-use, 2018 - 2030 (USD Million)
  • Table 58 Sweden Heparin market, by source, 2018 - 2030 (USD Million)
  • Table 59 Norway Heparin market, by type, 2018 - 2030 (USD Million)
  • Table 60 Norway Heparin market, by route of administration, 2018 - 2030 (USD Million)
  • Table 61 Norway Heparin market, by application, 2018 - 2030 (USD Million)
  • Table 62 Norway Heparin market, by end-use, 2018 - 2030 (USD Million)
  • Table 63 Norway Heparin market, by source, 2018 - 2030 (USD Million)
  • Table 64 Asia Pacific Heparin market, by region, 2018 - 2030 (USD Million)
  • Table 65 Asia Pacific Heparin market, by type, 2018 - 2030 (USD Million)
  • Table 66 Asia Pacific Heparin market, by route of administration, 2018 - 2030 (USD Million)
  • Table 67 Asia Pacific Heparin market, by application, 2018 - 2030 (USD Million)
  • Table 68 Asia Pacific Heparin market, by end-use, 2018 - 2030 (USD Million)
  • Table 69 Asia Pacific Heparin market, by source, 2018 - 2030 (USD Million)
  • Table 70 China Heparin market, by type, 2018 - 2030 (USD Million)
  • Table 71 China Heparin market, by route of administration, 2018 - 2030 (USD Million)
  • Table 72 China Heparin market, by application, 2018 - 2030 (USD Million)
  • Table 73 China Heparin market, by end-use, 2018 - 2030 (USD Million)
  • Table 74 China Heparin market, by source, 2018 - 2030 (USD Million)
  • Table 75 Japan Heparin market, by type, 2018 - 2030 (USD Million)
  • Table 76 Japan Heparin market, by route of administration, 2018 - 2030 (USD Million)
  • Table 77 Japan Heparin market, by application, 2018 - 2030 (USD Million)
  • Table 78 Japan Heparin market, by end-use, 2018 - 2030 (USD Million)
  • Table 79 Japan Heparin market, by source, 2018 - 2030 (USD Million)
  • Table 80 India Heparin market, by type, 2018 - 2030 (USD Million)
  • Table 81 India Heparin market, by route of administration, 2018 - 2030 (USD Million)
  • Table 82 India Heparin market, by application, 2018 - 2030 (USD Million)
  • Table 83 India Heparin market, by end-use, 2018 - 2030 (USD Million)
  • Table 84 India Heparin market, by source, 2018 - 2030 (USD Million)
  • Table 85 South Korea Heparin market, by type, 2018 - 2030 (USD Million)
  • Table 86 South Korea Heparin market, by route of administration, 2018 - 2030 (USD Million)
  • Table 87 South Korea Heparin market, by application, 2018 - 2030 (USD Million)
  • Table 88 South Korea Heparin market, by end-use, 2018 - 2030 (USD Million)
  • Table 89 South Korea Heparin market, by source, 2018 - 2030 (USD Million)
  • Table 90 Australia Heparin market, by type, 2018 - 2030 (USD Million)
  • Table 91 Australia Heparin market, by route of administration, 2018 - 2030 (USD Million)
  • Table 92 Australia Heparin market, by application, 2018 - 2030 (USD Million)
  • Table 93 Australia Heparin market, by end-use, 2018 - 2030 (USD Million)
  • Table 94 Australia Heparin market, by source, 2018 - 2030 (USD Million)
  • Table 95 Thailand Heparin market, by type, 2018 - 2030 (USD Million)
  • Table 96 Thailand Heparin market, by route of administration, 2018 - 2030 (USD Million)
  • Table 97 Thailand Heparin market, by application, 2018 - 2030 (USD Million)
  • Table 98 Thailand Heparin market, by end-use, 2018 - 2030 (USD Million)
  • Table 99 Thailand Heparin market, by source, 2018 - 2030 (USD Million)
  • Table 100 Latin America Heparin market, by region, 2018 - 2030 (USD Million)
  • Table 101 Latin America Heparin market, by type, 2018 - 2030 (USD Million)
  • Table 102 Latin America Heparin market, by route of administration, 2018 - 2030 (USD Million)
  • Table 103 Latin America Heparin market, by application, 2018 - 2030 (USD Million)
  • Table 104 Latin America Heparin market, by end-use, 2018 - 2030 (USD Million)
  • Table 105 Latin America Heparin market, by source, 2018 - 2030 (USD Million)
  • Table 106 Brazil Heparin market, by type, 2018 - 2030 (USD Million)
  • Table 107 Brazil Heparin market, by route of administration, 2018 - 2030 (USD Million)
  • Table 108 Brazil Heparin market, by application, 2018 - 2030 (USD Million)
  • Table 109 Brazil Heparin market, by end-use, 2018 - 2030 (USD Million)
  • Table 110 Brazil Heparin market, by source, 2018 - 2030 (USD Million)
  • Table 111 Mexico Heparin market, by type, 2018 - 2030 (USD Million)
  • Table 112 Mexico Heparin market, by route of administration, 2018 - 2030 (USD Million)
  • Table 113 Mexico Heparin market, by application, 2018 - 2030 (USD Million)
  • Table 114 Mexico Heparin market, by end-use, 2018 - 2030 (USD Million)
  • Table 115 Mexico Heparin market, by source, 2018 - 2030 (USD Million)
  • Table 116 Argentina Heparin market, by type, 2018 - 2030 (USD Million)
  • Table 117 Argentina Heparin market, by route of administration, 2018 - 2030 (USD Million)
  • Table 118 Argentina Heparin market, by application, 2018 - 2030 (USD Million)
  • Table 119 Argentina Heparin market, by end-use, 2018 - 2030 (USD Million)
  • Table 120 Argentina Heparin market, by source, 2018 - 2030 (USD Million)
  • Table 121 MEA Heparin market, by region, 2018 - 2030 (USD Million)
  • Table 122 MEA Heparin market, by type, 2018 - 2030 (USD Million)
  • Table 123 MEA Heparin market, by route of administration, 2018 - 2030 (USD Million)
  • Table 124 MEA Heparin market, by application, 2018 - 2030 (USD Million)
  • Table 125 MEA Heparin market, by end-use, 2018 - 2030 (USD Million)
  • Table 126 MEA Heparin market, by source, 2018 - 2030 (USD Million)
  • Table 127 South Africa Heparin market, by type, 2018 - 2030 (USD Million)
  • Table 128 South Africa Heparin market, by route of administration, 2018 - 2030 (USD Million)
  • Table 129 South Africa Heparin market, by application, 2018 - 2030 (USD Million)
  • Table 130 South Africa Heparin market, by end-use, 2018 - 2030 (USD Million)
  • Table 131 South Africa Heparin market, by source, 2018 - 2030 (USD Million)
  • Table 132 Saudi Arabia Heparin market, by type, 2018 - 2030 (USD Million)
  • Table 133 Saudi Arabia Heparin market, by route of administration, 2018 - 2030 (USD Million)
  • Table 134 Saudi Arabia Heparin market, by application, 2018 - 2030 (USD Million)
  • Table 135 Saudi Arabia Heparin market, by end-use, 2018 - 2030 (USD Million)
  • Table 136 Saudi Arabia Heparin market, by source, 2018 - 2030 (USD Million)
  • Table 137 UAE Heparin market, by type, 2018 - 2030 (USD Million)
  • Table 138 UAE Heparin market, by route of administration, 2018 - 2030 (USD Million)
  • Table 139 UAE Heparin market, by application, 2018 - 2030 (USD Million)
  • Table 140 UAE Heparin market, by end-use, 2018 - 2030 (USD Million)
  • Table 141 UAE Heparin market, by source, 2018 - 2030 (USD Million)
  • Table 142 Kuwait Heparin market, by type, 2018 - 2030 (USD Million)
  • Table 143 Kuwait Heparin market, by route of administration, 2018 - 2030 (USD Million)
  • Table 144 Kuwait Heparin market, by application, 2018 - 2030 (USD Million)
  • Table 145 Kuwait Heparin market, by end-use, 2018 - 2030 (USD Million)
  • Table 146 Kuwait Heparin market, by source, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 Primary interviews in North America
  • Fig. 5 Primary interviews in Europe
  • Fig. 6 Primary interviews in APAC
  • Fig. 7 Primary interviews in Latin America
  • Fig. 8 Primary interviews in MEA
  • Fig. 9 Market research approaches
  • Fig. 10 Value-chain-based sizing & forecasting
  • Fig. 11 QFD modeling for market share assessment
  • Fig. 12 Market formulation & validation
  • Fig. 13 Heparin market: market outlook
  • Fig. 14 Heparin competitive insights
  • Fig. 15 Parent market outlook
  • Fig. 16 Related/ancillary market outlook
  • Fig. 17 Penetration and growth prospect mapping
  • Fig. 18 Industry value chain analysis
  • Fig. 19 Heparin market driver impact
  • Fig. 20 Heparin market restraint impact
  • Fig. 21 Heparin market strategic initiatives analysis
  • Fig. 22 Heparin market: Type movement analysis
  • Fig. 23 Heparin market: Type outlook and key takeaways
  • Fig. 24 Low molecular weight heparin market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 25 Ultra-low molecular weight heparin market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 26 Unfractionated Heparin market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 27 Heparin market: Route of Administration movement Analysis
  • Fig. 28 Heparin market: Route of Administration outlook and key takeaways
  • Fig. 29 Intravenous market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 30 Subcutaneous market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 31 Heparin market: Application movement analysis
  • Fig. 32 Heparin market: Application outlook and key takeaways
  • Fig. 33 Venous thromboembolism market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 34 Atrial fibrillation market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 35 Renal impairment market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 36 Coronary artery disease market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 37 Others market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 38 Heparin market: End-use movement analysis
  • Fig. 39 Heparin market: End-use outlook and key takeaways
  • Fig. 40 Outpatient market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 41 Inpatient market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 42 Heparin market: Source movement analysis
  • Fig. 43 Heparin market: Source outlook and key takeaways
  • Fig. 44 Porcine market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 45 Bovine market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 46 Others market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 47 Global Heparin market: Regional movement analysis
  • Fig. 48 Global Heparin market: Regional outlook and key takeaways
  • Fig. 49 Global Heparin market share and leading players
  • Fig. 50 North America market share and leading players
  • Fig. 51 Europe market share and leading players
  • Fig. 52 Asia Pacific market share and leading players
  • Fig. 53 Latin America market share and leading players
  • Fig. 54 Middle East & Africa market share and leading players
  • Fig. 55 North America: SWOT
  • Fig. 56 Europe SWOT
  • Fig. 57 Asia Pacific SWOT
  • Fig. 58 Latin America SWOT
  • Fig. 59 MEA SWOT
  • Fig. 60 North America, by country
  • Fig. 61 North America
  • Fig. 62 North America market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 63 U.S.
  • Fig. 64 U.S. market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 65 Canada
  • Fig. 66 Canada market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 67 Europe
  • Fig. 68 Europe market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 69 UK
  • Fig. 70 UK market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 71 Germany
  • Fig. 72 Germany market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 73 France
  • Fig. 74 France market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 75 Italy
  • Fig. 76 Italy market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 77 Spain
  • Fig. 78 Spain market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 79 Denmark
  • Fig. 80 Denmark market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 81 Sweden
  • Fig. 82 Sweden market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 83 Norway
  • Fig. 84 Norway market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 85 Asia Pacific
  • Fig. 86 Asia Pacific market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 87 China
  • Fig. 88 China market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 89 Japan
  • Fig. 90 Japan market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 91 India
  • Fig. 92 India market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 93 Thailand
  • Fig. 94 Thailand market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 95 South Korea
  • Fig. 96 South Korea market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 97 Australia
  • Fig. 98 Australia market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 99 Latin America
  • Fig. 100 Latin America market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 101 Brazil
  • Fig. 102 Brazil market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 103 Mexico
  • Fig. 104 Mexico market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 105 Argentina
  • Fig. 106 Argentina market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 107 Middle East and Africa
  • Fig. 108 Middle East and Africa market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 109 South Africa
  • Fig. 110 South Africa market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 111 Saudi Arabia
  • Fig. 112 Saudi Arabia market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 113 UAE
  • Fig. 114 UAE market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 115 Kuwait
  • Fig. 116 Kuwait market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 117 Market share of key market players- Heparin market